COMPARATIVE GENETICS OF SKELETAL DEFECTS

骨骼缺陷的比较遗传学

• 批准号: 6954230
• 负责人: Richard M Harland
• 金额: $ 34.2万
• 依托单位: UNIVERSITY OF CALIFORNIA BERKELEY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-09-30 至 2009-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6954230
• 关键词: Xenopus; biochemical evolution; bone development disorder; comparative genomic hybridization; congenital oral /facial /cranial defect; congenital skeletal disorder; developmental genetics; functional /structural genomics; gene expression; gene mutation; gene targeting; genetic regulation; genetic regulatory element; genetic transcription; genetically modified animals; histology; laboratory mouse; limb bone; linkage mapping; physiologic bone resorption

DESCRIPTION (provided by applicant): The goal of this research is to understand the molecular mechanisms by which congenital skeletal disorders lead to pronounced developmental and radiological bone alterations. In particular the PIs are interested in two progressive hyperosteosis disorders: Van Buchem disease (VB) (MIM 239100) and Sclerosteosis (MIM 269500). VB is a severe, autosomal-recessive bone disorder characterized by cranio-facial distortion and generalized bone overgrowth. Sclerosteosis is a skeletal dysplasia highly similar to VB but with more pronounced radiological bone alterations (jaw; long bones; gigantism) and the presence of hand abnormalities (syndactyly). Linkage analysis mapped both diseases to the same locus (17q12-q21), and Sclerosteosis patients were found to carry several coding mutations in the BMP-antagonist gene Sclerostin (Sost). In contrast, VB patients exhibit no Sost coding mutations, however displayed a 52kb noncoding deletion, 35kb downstream of the Sost transcript. Using human transgenes in mice, the PIs have demonstrated that sclerosteosis and VB are allelic, and that the 52kb deletion removes essential Sost transcriptional regulatory elements, altering the human Sost expression pattern. Also, in mice, increased levels of Sost result in severe limb abnormalities (fused and split digits), while the lack of mouse Sost leads to hyperosteosis. These initial observations suggest that Sost plays a critical role during limb development as well as throughout the adult-life controlling bone homeostasis in vertebrates. Since Sost is highly conserved from fishes to humans, the PIs are interested in elucidating the role of this molecule during skeletal development in different vertebrates. Accordingly, this grant focuses on deciphering several fundamental properties of Sost including 1) identification and characterization of Sost-specific regulatory elements, 2) determination of the role of Sost in limb patterning and adult bone homeostasis, and 3) investigation of the role of Sost across different vertebrate lineages.

描述（由申请人提供）：本研究的目的是了解先天性骨骼疾病导致显著发育和放射学骨改变的分子机制。pi尤其对两种进行性骨质增生疾病感兴趣：Van Buchem病（VB） （MIM 239100）和硬化（MIM 269500）。VB是一种严重的常染色体隐性骨疾病，以颅面畸形和全身骨过度生长为特征。硬化症是一种与VB高度相似的骨骼发育不良，但具有更明显的放射学骨骼改变（颌骨、长骨、巨人症）和手部异常（并指畸形）。连锁分析将这两种疾病定位到相同的位点（17q12-q21），并且发现硬化症患者携带bmp拮抗剂基因Sclerostin （Sost）的几个编码突变。相比之下，VB患者没有Sost编码突变，但在Sost转录物下游35kb处显示52kb的非编码缺失。在小鼠中使用人类转基因，pi已经证明硬化症和VB是等位基因，52kb的缺失去除了必需的Sost转录调控元件，改变了人类Sost的表达模式。此外，在小鼠中，Sost水平升高会导致严重的肢体异常（融合和分裂的手指），而小鼠Sost缺乏会导致骨质增生。这些初步的观察结果表明，Sost在四肢发育过程中起着关键作用，并在整个成年期控制脊椎动物的骨稳态。由于Sost从鱼类到人类都是高度保守的，因此pi对阐明该分子在不同脊椎动物骨骼发育过程中的作用感兴趣。因此，本基金的重点是破解Sost的几个基本特性，包括1)鉴定和表征Sost特异性调控元件，2)确定Sost在肢体模式和成人骨稳态中的作用，以及3)研究Sost在不同脊椎动物谱系中的作用。